Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Pelin

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Immunology|January 30, 2023
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOXJack T Whelan, Ragunath Singaravelu, Fuan Wang, et al.
Frontiers in Immunology|November 21, 2022
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancerMathieu J F Crupi, Zaid Taha, Thijs J A Janssen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2021
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infectionStephen Boulton, Joanna Poutou, Nikolas T Martin, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2021
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variantLucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature Biomedical Engineering|November 28, 2024
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic virusesReza Rezaei, Stephen Boulton, Mahsa Ahmadi, et al.
Nature|December 23, 2021
Evolution of enhanced innate immune evasion by SARS-CoV-2Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature Communications|April 8, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapyMarie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi, et al.
Research Square|May 25, 2021
CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processesMeghna Gupta, Caleigh M Azumaya, Michelle Moritz, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processesMeghna Gupta, Caleigh M Azumaya, Michelle Moritz, et al.
Cell|September 22, 2023
SARS-CoV-2 variants evolve convergent strategies to remodel the host responseMehdi Bouhaddou, Ann-Kathrin Reuschl, Benjamin J Polacco, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Immunology|January 30, 2023
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOXJack T Whelan, Ragunath Singaravelu, Fuan Wang, et al.
Frontiers in Immunology|November 21, 2022
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancerMathieu J F Crupi, Zaid Taha, Thijs J A Janssen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2021
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infectionStephen Boulton, Joanna Poutou, Nikolas T Martin, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2021
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variantLucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature Biomedical Engineering|November 28, 2024
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic virusesReza Rezaei, Stephen Boulton, Mahsa Ahmadi, et al.
Nature|December 23, 2021
Evolution of enhanced innate immune evasion by SARS-CoV-2Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature Communications|April 8, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapyMarie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi, et al.
Research Square|May 25, 2021
CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processesMeghna Gupta, Caleigh M Azumaya, Michelle Moritz, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processesMeghna Gupta, Caleigh M Azumaya, Michelle Moritz, et al.
Cell|September 22, 2023
SARS-CoV-2 variants evolve convergent strategies to remodel the host responseMehdi Bouhaddou, Ann-Kathrin Reuschl, Benjamin J Polacco, et al.
Pageof 4